MED Insider Trading Activity and SEC Form 4 Filings
MED insider trading summary
Over the past 12 months, insiders at Medifast Inc (MED) reported 13 open-market purchases worth $1.6M by 2 insiders and 2 sales worth $226K by 1 insider on SEC Form 4. Net insider buying was $1.3M.
Latest MED insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 4, 2026 | Parsa Kiai | Director | Buy | $9K (661 @ $13.03) |
| Oct 28, 2026 | Parsa Kiai | Director | Buy | $66K (5,399 @ $12.24) |
| Oct 28, 2026 | Parsa Kiai | Director | Buy | $2K (158 @ $12.24) |
| Sep 29, 2026 | Daniel R Chard | Director | Sell | $112K (9,544 @ $11.73) |
| Sep 28, 2026 | Daniel R Chard | Director | Sell | $114K (9,545 @ $11.98) |
| Aug 26, 2026 | Parsa Kiai | Director | Buy | $14K (1,175 @ $12.26) |
| Aug 26, 2026 | Parsa Kiai | Director | Buy | $515K (41,975 @ $12.26) |
| Aug 24, 2026 | Parsa Kiai | Director | Buy | $51K (4,211 @ $12.00) |
| Aug 24, 2026 | Parsa Kiai | Director | Buy | $1K (118 @ $12.00) |
| Aug 20, 2026 | Parsa Kiai | Director | Buy | $487K (41,975 @ $11.60) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.